Chemistry Faculty Scholarship
Document Type
Article
Publication Date
8-22-2005
Publication Title
Journal of Biological Chemistry
Keywords
Post-translational regulation, Adipose differentiation-related protein
Abstract
Adipose differentiation-related protein (ADRP) is localized to lipid droplets in most mammalian cells. ADRP, proposed to regulate
fatty acid mobilization and lipid droplet formation, is linked to lipid accumulation in foam cells of human atherosclerotic
lesions. In this report, we show that ADRP protein accumulates in Chinese hamster ovary fibroblastic cells cultured in the
presence of oleic acid but is destabilized when fatty acid sources are removed from culture serum. The latter effect was blocked
by the proteasome inhibitor MG132, whereas inhibitors of other proteolytic processes were ineffective. Pulse-chase experiments
confirmed that ADRP degradation is inhibited by MG132. Conditions that stimulate ADRP degradation also promoted the covalent
modification of ADRP by ubiquitin, whereas the addition of oleic acid to culture media, which promotes triacylglycerol deposition,
blunted the appearance of ubiquitinated-ADRP. Treatment with MG132 increased the levels of ADRP associated with lipid droplets,
as well as throughout the cytosol. Finally, we demonstrate that the disappearance of ADRP protein after the onset of perilipin
expression during adipocyte differentiation is due to degradation by proteasomes Thus, proteolytic degradation of ADRP mediated
through the ubiquitin/proteasome pathway appears to be a major mode for the post-translational regulation of ADRP.
First Page
42841
Last Page
42847
Volume
280
Issue
52
Repository Citation
Tansey, John, "Post-translational Regulation of Adipose Differentiation-related Protein by the Ubiquitin/Proteasome Pathway" (2005). Chemistry Faculty Scholarship. 5.
https://digitalcommons.otterbein.edu/chem_fac/5
DOI
10.1074/jbc.M506569200
Version
Publisher's Version
Peer Reviewed
1
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.